Stable and discriminating radiomic predictor of recurrence in early stage non-small cell lung cancer: Multi-site study.
Lung Cancer(2020)
摘要
•Surgery is a potentially curative treatment modality for early-stage NSCLC.•Despite the curative intent of therapy, about 40–55 % of NSCLC develop recurrence.•There is no consensus regarding the use of histologic markers about adjuvant therapy.•There is no non-invasive biomarker to identify cancer recurrence post-surgery.•Stable and discriminate radiomic features can predict cancer recurrence post-surgery.
更多查看译文
关键词
NSCLC,Surgery,Adjuvant chemotherapy,Radiomics,Quantitative imaging
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络